Precision BioSciences Inc. Form 8-K Summary
Business Context and Reporting Period
Precision BioSciences Inc. (DTIL), a Delaware corporation, filed this Current Report on Form 8-K on January 11, 2021. The company is an emerging growth company with its principal executive offices in Durham, North Carolina. Its common stock trades on the Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely as a disclosure of investor communications.
Material Changes
No material financial changes or operational updates are reported in this filing. The report is limited to the announcement of upcoming investor meetings.
Guidance, Outlook, and Management Commentary
Under Item 7.01 (Regulation FD Disclosure), the Company announced it will participate in meetings with investors and analysts. Presentation materials for these meetings are available on the Company's Investor Relations website. The filing explicitly states that the information contained in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the investor presentation materials available on the company's website.
- Confirm the dates and times of the upcoming investor and analyst meetings.
- Review the company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.